In the latest edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Sara Naseri, MD, co-founder and CEO of women’s health company, Qvin (, about the Q-Pad, an FDA-cleared menstrual pad designed to collect blood to be processed for diagnostic purposes.

In this wide-ranging discussion, Naseri and Wolski discuss how she came up with this unique, out-of-the-box idea; how the company plans to overcome the taboos associated with menstruation; how the Q-pad will improve access to health care; and the company’s plans for the future.